Search

everythinglearnresearchcommunity

for

Search:↓

Tjalma Syndrome is a rare condition in people with lupus, causing fluid buildup and high CA-125 levels, but not due to tumors.

Cupric chloride treatment corrected abnormal Purkinje cell development in brindled mice.

Jiawei Erzhiwan helps hair growth in androgenetic alopecia by affecting specific cell pathways.

MRL/MpJ mice's skin wounds heal with scars, unlike their ear wounds which can regenerate.

Targeting specific metabolic and ionic pathways may improve alopecia areata treatment.

Wharton's jelly stem cells show diverse traits and functions.

JAK inhibitors are effective for treating alopecia areata, with most patients seeing hair growth after treatment.

Oral JAK inhibitors effectively treat alopecia areata and are generally well-tolerated.

Janus kinase inhibitors may help treat cutaneous T-cell lymphoma, but more research is needed.

A genetic mutation in the LIPH gene causes tightly curled hair that stops growing in some Japanese individuals.

A gene deletion causes the "hairless" trait in Iffa Credo rats.

Different STUB1 gene mutations cause varied symptoms in autosomal recessive ataxias.

Experts created guidelines for who in Australia can get subsidized JAK inhibitor therapy for alopecia areata.

The document corrected previous errors and announced future dermatology events.

HtrA2 activity is crucial for normal hair growth by regulating fat cell development.

A rare ITGB6 gene variant causes intellectual disability, hair loss, and dental issues.

BMP2 and BMPR-IA may stop hair growth while Noggin may encourage it in yak skin.

Notch/RBP-J signaling is crucial for proper placement and timing of melanocyte development in hair follicles.

Baricitinib is an effective treatment for severe alopecia areata.

The lemur's testicular tumor was removed, improving its coat and behavior, with no signs of cancer spread.

A Gsdma3 mutation causes hair loss due to stem cell damage from skin inflammation.

The enzyme Dgat1 is essential for healthy hair and skin by controlling retinoid levels.

Upadacitinib may effectively treat both alopecia universalis and Crohn's disease.

Ruxolitinib treatment led to unexpected hair regrowth in a patient with alopecia universalis.

Ruxolitinib may effectively treat APS-1 by reducing harmful immune responses.

The most different genetic segment between Africans and East Asians is the EDA2R/AR region, with two main types influenced by population changes and natural selection, and linked to baldness.

Pseudopelade can affect both the scalp and beard, causing hair loss.

Edar signaling is crucial for proper hair follicle development and function.